Trials Sponsors Conditions Drugs Pricing

Conditions

Idiopathic Macular Holes

Keywords

Macular hole surgerymembranepeelingclosure ratevitreoretinal dyes

Outcome Measures

Primary Outcomes (1)

Macular Hole Closure Rate
12 Months

Secondary Outcomes (1)

Visual Acuity Microperimetry Optical Coherence Tomography
12 Months

Study Arms (2)

Group 1

ACTIVE COMPARATOR

Brillant Blue

Procedure: Brillant Blue

Group 2

ACTIVE COMPARATOR

Indocyanine Green

Procedure: Indocyanine Green

Interventions

Brillant BlueProcedure

Membrane Peeling with Brillant Blue

Group 1

Indocyanine GreenProcedure

Membrane Peeling with indocyanine Green

Group 2

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age60 Years+

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Idiopathic stage 3 and 4 macular holes
Stage 2 macular holes, followed up for at least 6 months

Sponsors & Collaborators

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Otherlead

Study Sites (1)

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser surgery

Vienna, State of Vienna, 1030, Austria

MeSH Terms

Interventions

procion brilliant blue HGRIndocyanine Green

Intervention Hierarchy (Ancestors)

IndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Officials

Katharina Kreppler, MD
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
STUDY CHAIR
Christiane I Falkner-Radler, MD
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
PRINCIPAL INVESTIGATOR

Enrollment

60 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: OUTCOMES ASSESSOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: MD

Study Record Dates

First Submitted

September 21, 2008

First Posted

September 23, 2008

Study Start

August 2008

Date type not reported

This date has not been verified as actual or estimated.

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Group 1

Group 2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Group 1

Group 2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations